06:28 AM EST, 02/06/2025 (MT Newswires) -- Haemonetics ( HAE ) reported fiscal Q3 adjusted earnings Thursday of $1.19 per diluted share, up from $1.04 a year earlier.

Three analysts polled by FactSet expected $1.11.

Net revenue for the quarter ended Dec. 28 was $348.5 million, up from $336.3 million.

Analysts polled by FactSet expected $353 million.

The company narrowed its fiscal year 2025 adjusted EPS to $4.50 to $4.70 from $4.45 to $4.75. Three analysts surveyed by FactSet are looking for $4.35.